Humalog 200 U/ml Kwikpen Inj 3ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty tissue under the skin. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique.
Administration Instructions
Take the medication within 15 minutes before or immediately after a meal.
Rotate the injection site each time to avoid tissue damage.
Avoid injecting into skin that is thickened, has pits or lumps, or is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
Do not use the medication if the solution appears cloudy, is leaking, or contains particles, or if the solution has changed color.
Preparing the Dose
Remove all pen needle covers before injecting a dose. If you have any questions about the type of pen needle you are using or how to use it, consult your doctor.
Be aware that the device may produce a clicking sound when preparing the dose. However, do not rely on the clicks to determine the correct dose, as this could lead to an incorrect dose being administered.
After each injection, remove the needle from the device and do not store the device with the needle attached.
Safety Precautions
Do not transfer the medication from the pen to a syringe or mix it with other types of insulin.
Dispose of used needles in a designated needle/sharp disposal box. Do not reuse needles or other items, and follow local regulations for disposing of the box when it is full. If you have any questions, consult your doctor or pharmacist.
Diet and Exercise
Follow the diet and exercise plan recommended by your doctor.
Be aware of what to do if you miss a meal or do not eat as much as usual.
Storage and Disposal
Store unopened containers in the refrigerator. Do not freeze the medication, and do not use it if it has been frozen.
Missed Dose
* If you forget to take a dose, be aware of the steps to take. If you are unsure, contact your doctor for guidance.
Lifestyle & Tips
- Follow your prescribed diet plan, including carbohydrate counting if advised.
- Engage in regular physical activity as recommended by your doctor.
- Monitor your blood glucose levels regularly as instructed.
- Rotate injection sites within the same general area (e.g., abdomen, thigh, upper arm) to prevent lipodystrophy.
- Never share your KwikPen with another person, even if the needle is changed, due to risk of infection.
Available Forms & Alternatives
Available Strengths:
- Humalog Insulin (vl-7510) 10ml
- Humalog Mix 75/25 Vial 10ml
- Humalog Cartridge 3ml
- Humalog Mix 50/50 Inj, 10ml
- Humalog Mix 50/50 Kwikpen Inj 3ml
- Humalog 100 U/ml Kwik Pen Inj 3ml
- Humalog Mix 75/25 Kwikpen Inj 3ml
- Humalog 100u/ml Vial 3ml
- Humalog 200 U/ml Kwikpen Inj 3ml
- Humalog Jr 100u/ml Kwikpnhalf Unit
- Humalog Tempo Pen 100u/ml Inj 3ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Note: In rare cases, allergic reactions can be fatal.
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ An irregular heartbeat
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Local reactions at the injection site, including:
+ Thick skin
+ Pits or lumps
Swelling in the arms or legs
Low blood sugar, which may cause:
+ Dizziness or fainting
+ Blurred vision
+ Mood changes
+ Slurred speech
+ Headache
+ Fatigue or weakness
+ Shaking
+ Rapid heartbeat
+ Confusion
+ Hunger
+ Sweating
+ Seizures
If you experience any of these symptoms, contact your doctor immediately. If you have low blood sugar, follow your doctor's instructions, which may include taking glucose tablets, liquid glucose, or certain fruit juices.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. Contact your doctor or seek medical help if you experience any of the following side effects or if they persist or bother you:
Weight gain
Flu-like symptoms
Nose or throat irritation
Common cold symptoms
Headache
Cough
Upset stomach
Stomach pain or diarrhea
Fatigue or weakness
* Irritation at the injection site
This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Signs of low blood sugar (hypoglycemia): sweating, shakiness, dizziness, confusion, hunger, irritability, blurred vision. Treat immediately with fast-acting sugar.
- Signs of high blood sugar (hyperglycemia): increased thirst, frequent urination, fatigue, blurred vision. Contact your doctor if persistent.
- Signs of allergic reaction: rash, itching, hives, swelling of face/lips/tongue/throat, difficulty breathing. Seek immediate medical attention.
- Signs of injection site reactions: redness, swelling, itching, pain, or lumps at the injection site. Report persistent or severe reactions.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have low blood sugar (hypoglycemia), as this may affect your treatment plan.
This is not an exhaustive list of potential interactions. To ensure your safety, it is crucial to disclose all of the following to your doctor and pharmacist:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
* Your complete medical history, including any health problems you have
Before starting, stopping, or changing the dose of any medication, including this one, you must consult with your doctor to confirm that it is safe to do so. This will help prevent any potential interactions or adverse effects.
Precautions & Cautions
This drug can cause low blood sugar, which may lead to seizures, loss of consciousness, permanent brain damage, and even death if not properly managed. It is crucial to discuss this risk with your doctor. Additionally, this medication can cause low blood potassium levels, which, if left untreated, can result in abnormal heart rhythms, severe breathing difficulties, and potentially death. If you experience any symptoms, consult your doctor promptly.
Until you understand how this drug affects you, avoid driving and other activities that require your full attention. Certain diabetes medications, such as pioglitazone or rosiglitazone, may increase the risk of heart failure, especially when used in combination with insulin. If you are taking one of these medications, consult your doctor to discuss the potential risks.
Ensure you have the correct insulin product and understand how to measure and prepare your dose, as insulin products are available in various containers, including vials, cartridges, and pens. If you have any questions or concerns, contact your doctor or pharmacist.
Your blood sugar levels may be more challenging to control during periods of stress, such as illness, infection, injury, or surgery. Changes in physical activity, exercise, or diet can also impact your blood sugar levels.
It is recommended that you wear a medical alert identification to ensure prompt treatment in case of an emergency. Avoid driving if you have experienced low blood sugar, as it can increase your risk of being involved in an accident.
Regularly check your blood sugar levels as instructed by your doctor and undergo blood tests as recommended to monitor your condition.
Be aware that this particular brand of insulin is twice as potent as other brands, requiring extra caution when measuring your dose to avoid accidental overdose, which can lead to severe side effects or life-threatening low blood sugar. Consult your doctor if you have any concerns.
This insulin product is not suitable for use in an insulin pump. If you have any questions or concerns, discuss them with your doctor.
Before consuming alcohol or using products containing alcohol, consult your doctor to understand the potential risks and interactions.
Do not share your insulin product or any related devices, including pens, cartridge devices, needles, or syringes, with others, even if the needle has been changed, as this can transmit infections.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to discuss the benefits and risks of this medication for both you and your baby.
Overdose Information
Overdose Symptoms:
- Severe hypoglycemia (low blood sugar)
- Confusion
- Seizures
- Loss of consciousness
- Coma
What to Do:
For mild hypoglycemia, consume oral glucose (e.g., glucose tablets, fruit juice, candy). For severe hypoglycemia, administer glucagon injection if available, or seek immediate medical attention. Call 911 or your local emergency number. Call 1-800-222-1222 for Poison Control.
Drug Interactions
Major Interactions
- Drugs that may increase the risk of hypoglycemia: Oral antidiabetic agents, ACE inhibitors, angiotensin receptor blockers (ARBs), disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), sulfonamide antibiotics.
- Drugs that may decrease the blood glucose lowering effect: Corticosteroids, diuretics (thiazide and loop), sympathomimetics (e.g., epinephrine, albuterol, terbutaline), growth hormone, danazol, isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, atypical antipsychotics (e.g., olanzapine, clozapine).
Monitoring
Baseline Monitoring
Rationale: To establish baseline glycemic control and guide initial dosing.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline glucose levels.
Timing: Prior to initiation of therapy.
Rationale: To assess kidney function, as insulin clearance can be affected by renal impairment.
Timing: Prior to initiation of therapy.
Rationale: To assess liver function, as insulin metabolism can be affected by hepatic impairment.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Multiple times daily (e.g., pre-meal, 1-2 hours post-meal, bedtime, overnight as needed)
Target: Individualized, typically 80-130 mg/dL pre-meal, <180 mg/dL post-meal
Action Threshold: Hypoglycemia (<70 mg/dL) or Hyperglycemia (>180-250 mg/dL depending on target)
Frequency: Every 3-6 months
Target: <7% for most adults (individualized)
Action Threshold: >7% (or individualized target) indicates need for therapy adjustment
Frequency: Periodically (e.g., every 3-6 months)
Target: Maintain healthy weight
Action Threshold: Significant unexplained weight gain or loss
Frequency: Regularly (e.g., daily)
Target: No signs of lipodystrophy, redness, swelling
Action Threshold: Presence of lipohypertrophy, atrophy, or signs of infection
Symptom Monitoring
- Symptoms of hypoglycemia: sweating, tremor, dizziness, confusion, hunger, irritability, blurred vision, headache, rapid heartbeat.
- Symptoms of hyperglycemia: increased thirst, increased urination, fatigue, blurred vision, unexplained weight loss.
- Symptoms of allergic reaction: rash, itching, hives, swelling of face/lips/tongue/throat, difficulty breathing.
Special Patient Groups
Pregnancy
Insulin lispro is generally considered safe and is the preferred treatment for diabetes in pregnancy. Careful monitoring of blood glucose is essential to achieve optimal glycemic control.
Trimester-Specific Risks:
Lactation
Insulin lispro is considered compatible with breastfeeding. Insulin is a normal component of breast milk and is not expected to cause adverse effects in a breastfed infant.
Pediatric Use
Humalog U-200 KwikPen is not recommended for use in pediatric patients. Humalog U-100 is typically used for pediatric patients requiring insulin lispro.
Geriatric Use
Use with caution in elderly patients due to increased risk of hypoglycemia, particularly in those with renal or hepatic impairment. Start with lower doses and titrate slowly. Monitor blood glucose levels more frequently.
Clinical Information
Clinical Pearls
- Humalog U-200 KwikPen is a concentrated insulin (200 units/mL) and should only be used with the specific KwikPen device. Do NOT transfer the insulin from the pen to a syringe, as this can lead to significant dosing errors and severe hypoglycemia.
- This formulation is intended for adult patients requiring more than 20 units of rapid-acting insulin per day, as it allows for a smaller injection volume.
- Always verify the insulin concentration (U-100 vs U-200) before administration to prevent dosing errors.
- Administer 5-10 minutes before a meal or within 20 minutes after starting a meal. The timing is crucial for optimal postprandial glucose control.
- Rotate injection sites within the same general area to reduce the risk of lipodystrophy (lumps or indentations in the skin).
- Patients should be educated on the signs and symptoms of hypoglycemia and how to treat it promptly.
Alternative Therapies
- Other rapid-acting insulin analogs (e.g., insulin aspart, insulin glulisine, insulin lispro U-100)
- Short-acting human insulin (e.g., Regular insulin)
- Other classes of antidiabetic agents (e.g., metformin, sulfonylureas, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, thiazolidinediones)